# Arcadia Biosciences, Inc.: Form 8-K, filed May 17, 2024

- Company: [Arcadia Biosciences, Inc.](/companies/rkda.md) (CIK 1469443)
- Form: 8-K
- Filed: 2024-05-17
- Accepted by EDGAR: May 17, 2024, 15:15 ET
- Period: 2024-05-13
- Accession: 0000950170-24-061526
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1469443/000095017024061526/rkda-20240513.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1469443/000095017024061526/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1469443/000095017024061526/rkda-20240513.htm

Filed May 17, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-061526. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.